SEC 13F Intelligence

Sivik Global Healthcare LLC / DXCM

Sivik Global Healthcare LLC’s Dexcom Inc Position

Does Sivik Global Healthcare LLC own Dexcom Inc (DXCM)? Not currently — the last reported position was 30.0K shares worth $3M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q2 2024
Shares
30.0K
% of Portfolio
+1.22%
Quarters Held
6
position exited

Position History DXCM

Reported value by quarter
Q4 ’18: $899,000Q4 ’18Q1 ’19: $1MQ1 ’19Q3 ’23: $5MQ3 ’23Q4 ’23: $6MQ4 ’23Q1 ’24: $5MQ1 ’24Q2 ’24: $3MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202430.0K$3M+1.22%
Q1 202435.0K$5M+1.14%
Q4 202350.0K$6M+2.59%
Q3 202350.0K$5M+2.36%
Q1 201912.5K$1M+0.55%
Q4 20187.5K$899,000+0.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of DXCM.